Merck quarterly profit beats estimates on Keytruda strength
U.S. drugmaker Merck & Co quarterly profit edged past Wall Street estimates on Friday, as its blockbuster cancer drug Keytruda brought in over $2 billion for the first time in a quarter. Shares of the […]